T lymphocyte response against pancreatic cell antigens in fulminant Type 1 diabetes

Diabetologia

Volumn 47, Issue 7, 2004, Pages 1285-1291

  Kotani, R ^a   Nagata, M ^a   Imagawa, A ^b,c   Moriyama, H ^a   Yasuda, H ^a   Miyagawa, J ^c   Hanafusa, T ^b   Yokono, K ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Autoimmune; ELISPOT; Fulminant; T cell; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CELL ANTIGEN; GLUTAMATE DECARBOXYLASE; INSULIN; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HLA TYPING; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

EID: 4143079343     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1441-4     Document Type: Article

References (26)

1. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
2. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 [Suppl 1]:S5-S20
3. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y (2000) A novel subtype of Type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 342:301-307
4. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y (2000) A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence. Ann Med 32:539-543
5. Imagawa A, Hanafusa T, Uchigata Y et al. (2003) Fulminant type 1 diabetes - a nationwide survey in Japan. Diabetes Care 26:2345-2352
6. Tanaka S, Kobayashi T, Momotsu T (2000) A novel subtype of type 1 diabetes mellitus (correspondence) letter 002. New Engl J Med 342:1835-1837
7. Shimada A, Oikawa Y, Shigihara T, Senda T, Kodama K (2002) A case of fulminant type 1 diabetes with strong evidence of autoimmunity. Diabetes Care 25:1482-1483
8. Sekine N, Motokura T, Oki T et al. (2000) Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 285:1153-1154
9. Vreugdenhil GR, Schloot NC, Hoorens A et al. (2000) Acute onset of type I diabetes mellitus after severe echo-virus 9 infection: putative pathogenic pathways. Clin Infect Dis 31:1025-1031
10. Kotani R, Nagata M, Moriyama H et al. (2002) Detection of GAD65-reactive T-cells in Type 1 diabetes by immunoglobulin-free ELISPOT assays. Diabetes Care 25:1390-1397
11. Masuda M, Powell M, Chen S et al. (2000) Autoantibodies to IA-2 in insulin-dependent diabetes measurement with a new immunoprecipitation assay. Clin Chim Acta 291:53-66
12. Bottazzo GF, Gleichmann H (1986) Immunology and Diabetes Workshops: reports of the first international workshop on the standardization of cytoplasmic islet cell antibodies. Diabetologia 29:125-126
13. 125I-labelled recombinant GAD65 produced in yeast. Clin Chim Acta 256:175-188
14. Hayakawa N, Premawardhana LD, Powell M et al. (2002) Isolation and characterization of human monoclonal antibodies to glutamic acid decarboxylase. Autoimmunity 35:343-355
15. Imagawa A, Hanafusa T, Tamura S et al. (2001) Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 50:1269-1273
16. Kawabata Y, Ikegami H, Kawaguchi Y et al. (2002) Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 51:545-551
17. Radu DL (2001) Cellular mechanisms involved in experimental insulin-dependent diabetes mellitus. Roum Arch Microbiol Immunol 60:203-226
18. Durinovic-Bello I, Hummel M, Ziegler AG (1996) Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 45:795-800
19. Katz DJ, Benoist C, Mathis D (1995) T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188
20. Harrison LC, Honeyman MC, Deaizpurua HJ et al. (1993) Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341:1365-1369
21. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L (1995) Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181:817-821
22. Bosi E, Minelli R, Bazzigaluppi E, Salvi M (2000) Fulminant autoimmune Type 1 diabetes during interferon-alpha therapy: a case of Thl-mediated disease? Diabet Med 18:329-332
23. Ikegami H, Ogihara T (1996) Genetics of insulin-dependent diabetes mellitus. Endocrine J 43:605-613
24. Jun HS, Yoon JW (2001) The role of viruses in type 1 diabetes: two distinct cellular and molecular pathogenetic mechanisms of virus-induced diabetes in animals. Diabetologia 44:271-285
25. Kitaura Y (1981) Experimental coxackie B virus myocarditi in mice. 18 month histopathological and virological study. Jpn Circ J 45:747-762
26. Nakamura H, Yamamura T, Umemoto S et al. (1996) Autoimmune response in chronic ongoing myocarditis demonstrated by heterotopic cardiac transplantation in mice. Circulation 94:3348-3354